Mitsubishi Tanabe Of Japan Apologizes For Quality-Check Failure
This article was originally published in PharmAsia News
Japan's Mitsubishi Tanabe Pharma apologized for failures to make quality checks that led to a voluntary recall of drugs made at its Mitsubishi Tanabe Pharma Factory
You may also be interested in...
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.
Janet Woodcock’s 2019 prediction that record ANDA approval volumes would not continue is confirmed with the FY 2020 approval total down 21% from the previous year.
Deal snapshot: Resolving a loose end from its 2014 buyout of Auxilium, Endo acquires all rights to Xiaflex, along with approved cellulite therapy Qwo.